Biliary Tract Cancer Completed Phase 2 Trials for Oxaliplatin (DB00526)

Also known as: Biliary tract cancer / Cancers, Biliary Tract / Malignant neoplasm of biliary tract, unspecified / Malignant tumor of biliary tract / Malignant neoplasm of biliary tract, part unspecified

IndicationStatusPhase
DBCOND0030617 (Biliary Tract Cancer)Completed2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00142480Capecitabine, Oxaliplatin, Bevacizumab and Radiation Therapy in Patients With Biliary Tract and Gallbladder CancerTreatment
NCT00361231Gemcitabine, Oxaliplatin in Combination With Bevacizumab in Biliary Tract and Gallbladder CancerTreatment
NCT01308840Gemcitabine, Oxaliplatin and Panitumumab in Kras/B-raf Wild-Type Biliary Track and Gallbladder CancerTreatment
NCT01572324Study of Hepatic Arterial Infusion to Treat Biliary Tract CarcinomasTreatment